Research on protein basis showed that high S100A/S100A9 expression could serve as an indicator for clinical outcomes in lung cancer, and this single-cell transcriptome study demonstrated significant expressions of these proteins in breast cancer lymph node metastases[39]. Here, S100A1 is linked to lung cancer.